DAVID A LOWE
Physician at Braemore Rd, Boston, MA
License number
Florida 14484
Issued Date
Dec 30, 2009
Effective Date
Jan 6, 2011
Expiration Date
Jun 30, 2011
Category
Health Care
Type
Registration for Resident/HSE Physician
Address
Address
2
15 Braemore Rd APT 3, Boston, MA 02135
1611 NW 12Th Ave, Miami, FL 33136
1611 NW 12Th Ave, Miami, FL 33136
Phone
(617) 487-5464
Organization information
See more information about DAVID A LOWE at bizstanding.comBoston Children's Hospital - David Lowe MD
300 Longwood Ave #FEGAN10, Boston, MA 02115
Categories:
Physicians & Surgeons
Site:
Phone:
(617) 355-6000 (Phone)
Products:
Cardiology
David Lowe BS,MBBS,MD
300 Longwood Ave, Boston, MA 02115
Industry:
Pediatrician
Phone:
(617) 355-6624 (Phone)
David Alexander Lowe
David Lowe MD
3100 SW 62 Ave #122, Miami, FL 33155
Categories:
Pediatrics Physicians & Surgeons
Phone:
(305) 666-6511 (Phone)
Dave's Bargain Center, Inc
2364 SW 13 St, Miami, FL 33145
Status:
Inactive
Industry:
Wholesales Gifts
Doing business as:
David Lowe
Registration:
May 4, 1984
Phone:
(305) 858-7999 (Phone)
State ID:
M00238
Business type:
Domestic for Profit Corporation
Directors:
David B. Lowe President, Director, inactive,Lenore Lowe Director, inactive
Professional information
David A Lowe, Miami FL
Specialties:
Pediatric Emergency Medicine
Age:
47
Address:
3100 SW 62Nd Ave, Miami 33155
(305) 666-6511 (Phone)
MIAMI CHILDRENS HOSPITAL
3100 SW 62Nd Ave, Miami 33155
(305) 666-6511 (Phone), (305) 663-9194 (Fax)
MIAMI CHILDRENS HOSPITAL
3100 SW 62Nd Ave, Miami 33155
(305) 666-6511 (Phone), (305) 665-1576 (Fax)
(305) 666-6511 (Phone)
MIAMI CHILDRENS HOSPITAL
3100 SW 62Nd Ave, Miami 33155
(305) 666-6511 (Phone), (305) 663-9194 (Fax)
MIAMI CHILDRENS HOSPITAL
3100 SW 62Nd Ave, Miami 33155
(305) 666-6511 (Phone), (305) 665-1576 (Fax)
Certifications:
Pediatric Emergency Medicine, 2013, Pediatrics, 2007
Awards:
Healthgrades Honor Roll
Languages:
English
David Alexander Lowe, Miami FL
Specialties:
Pediatrician
Address:
3100 Sw 62Nd Ave, Miami, FL 33155
Education:
Bachelor of Medicine, Bachelor of Surgery
Board certifications:
American Board of Pediatrics Certification in Pediatrics
Transgenic Flies Expressing Abeta42-Arctic
US Patent:
2005013, Jun 16, 2005
Filed:
Oct 21, 2004
Appl. No.:
10/969893
Inventors:
David Lowe - Boston MA, US
Gerhard Koenig - Arlington MA, US
Christopher Cummings - Brookline MA, US
Gerhard Koenig - Arlington MA, US
Christopher Cummings - Brookline MA, US
International Classification:
A01K067/033
US Classification:
800008000, 800009000
Abstract:
The present invention discloses a transgenic fly that expresses the Arctic mutant version of the human Aβ42 peptide of human amyloid-β precursor protein (APP), and a double transgenic fly that expresses both the Tau protein and the human Aβ42peptide of human amyloid-β precursor protein (APP). The transgenic flies of the present invention provide for models of neurodegenerative disorders, such as Alzheimer's disease. The invention further discloses methods for identifying genetic modifiers, as well as screening methods to identify therapeutic compounds to treat neurodegenerative disorders using the transgenic flies.
Transgenic Flies Expressing Abeta42-Flemish
US Patent:
2005013, Jun 16, 2005
Filed:
Oct 21, 2004
Appl. No.:
10/969895
Inventors:
David Lowe - Boston MA, US
Gerhard Koenig - Arlington MA, US
Christopher Cummings - Brookline MA, US
Gerhard Koenig - Arlington MA, US
Christopher Cummings - Brookline MA, US
International Classification:
A01K067/033
US Classification:
800008000, 800009000, 800013000
Abstract:
The present invention discloses a transgenic fly that expresses the Flemish mutant version of the human Aβ42 peptide of human amyloid-β precursor protein (APP), and a double transgenic fly that expresses both the Tau protein and the human Aβ42peptide of human amyloid-β precursor protein (APP). The transgenic flies of the present invention provide for models of neurodegenerative disorders, such as Alzheimer's disease. The invention further discloses methods for identifying genetic modifiers, as well as screening methods to identify therapeutic compounds to treat neurodegenerative disorders using the transgenic flies.
Transgenic Flies Expressing Abeta42-Iowa
US Patent:
2005013, Jun 16, 2005
Filed:
Oct 21, 2004
Appl. No.:
10/969894
Inventors:
David Lowe - Boston MA, US
Gerhard Koenig - Arlington MA, US
Christopher Cummings - Brookline MA, US
Gerhard Koenig - Arlington MA, US
Christopher Cummings - Brookline MA, US
International Classification:
A01K067/033
US Classification:
800008000, 800009000, 800013000
Abstract:
The present invention discloses a transgenic fly that expresses the Iowa mutant version of the human Aβ42 peptide of human amyloid-β precursor protein (APP), and a double transgenic fly that expresses both the Tau protein and the human Aβ42peptide of human amyloid-β precursor protein (APP). The transgenic flies of the present invention provide for models of neurodegenerative disorders, such as Alzheimer's disease. The invention further discloses methods for identifying genetic modifiers, as well as screening methods to identify therapeutic compounds to treat neurodegenerative disorders using the transgenic flies.
Transgenic Flies Expressing Abeta42-Dutch
US Patent:
2005013, Jun 16, 2005
Filed:
Oct 21, 2004
Appl. No.:
10/969898
Inventors:
David Lowe - Boston MA, US
Gerhard Koenig - Arlington MA, US
Christopher Cummings - Brookline MA, US
Gerhard Koenig - Arlington MA, US
Christopher Cummings - Brookline MA, US
International Classification:
A01K067/033
US Classification:
800008000, 800009000, 800013000
Abstract:
The present invention discloses a transgenic fly that expresses the Dutch mutant version of the human Aβ42 peptide of human amyloid-β precursor protein (APP), and a double transgenic fly that expresses both the Tau protein and the human Aβ42peptide of human amyloid-β precursor protein (APP). The transgenic flies of the present invention provide for models of neurodegenerative disorders, such as Alzheimer's disease. The invention further discloses methods for identifying genetic modifiers, as well as screening methods to identify therapeutic compounds to treat neurodegenerative disorders using the transgenic flies.
Transgenic Flies Expressing Abeta42-Flemish
US Patent:
2004024, Dec 2, 2004
Filed:
May 25, 2004
Appl. No.:
10/852892
Inventors:
David Lowe - Boston MA, US
Gerhard Koenig - Arlington MA, US
Christopher Cummings - Brookline MA, US
Gerhard Koenig - Arlington MA, US
Christopher Cummings - Brookline MA, US
Assignee:
EnVivo Pharmaceuticals, Inc.
International Classification:
A01K067/033
US Classification:
800/003000, 800/008000
Abstract:
The present invention discloses a transgenic fly that expresses the Flemish mutant version of the human A42 peptide of human amyloid- precursor protein (APP), and a double transgenic fly that expresses both the Tau protein and the human A42peptide of human amyloid- precursor protein (APP). The transgenic flies of the present invention provide for models of neurodegenerative disorders, such as Alzheimer's disease. The invention further discloses methods for identifying genetic modifiers, as well as screening methods to identify therapeutic compounds to treat neurodegenerative disorders using the transgenic flies.
Transgenic Flies Expressing Abeta42-Italian
US Patent:
2005013, Jun 16, 2005
Filed:
Oct 21, 2004
Appl. No.:
10/970189
Inventors:
David Lowe - Boston MA, US
Gerhard Koenig - Arlington MA, US
Christopher Cummings - Brookline MA, US
Gerhard Koenig - Arlington MA, US
Christopher Cummings - Brookline MA, US
International Classification:
A01K067/033
US Classification:
800008000, 800009000, 800013000
Abstract:
The present invention discloses a transgenic fly that expresses the Italian mutant version of the human Aβ42 peptide of human amyloid-β precursor protein (APP), and a double transgenic fly that expresses both the Tau protein and the human Aβ42peptide of human amyloid-β precursor protein (APP). The transgenic flies of the present invention provide for models of neurodegenerative disorders, such as Alzheimer's disease. The invention further discloses methods for identifying genetic modifiers, as well as screening methods to identify therapeutic compounds to treat neurodegenerative disorders using the transgenic flies.
Transgenic Flies Expressing Abeta42-Dutch
US Patent:
2004025, Dec 9, 2004
Filed:
May 25, 2004
Appl. No.:
10/853593
Inventors:
David Lowe - Boston MA, US
Gerhard Koenig - Arlington MA, US
Christopher Cummings - Brookline MA, US
Gerhard Koenig - Arlington MA, US
Christopher Cummings - Brookline MA, US
Assignee:
EnVivo Pharmaceuticals, Inc.
International Classification:
A01K067/033
US Classification:
800/008000, 800/009000
Abstract:
The present invention discloses a transgenic fly that expresses the Dutch mutant version of the human A42 peptide of human amyloid- precursor protein (APP), and a double transgenic fly that expresses both the Tau protein and the human A42peptide of human amyloid- precursor protein (APP). The transgenic flies of the present invention provide for models of neurodegenerative disorders, such as Alzheimer's disease. The invention further discloses methods for identifying genetic modifiers, as well as screening methods to identify therapeutic compounds to treat neurodegenerative disorders using the transgenic flies.
David Lowe
Location:
Greater Boston Area
Industry:
Pharmaceuticals